Sage Journals: Discover world-class research

Open access

Research article

First published 2018-8

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus

A Doria, D Bass, A Schwarting [...]

Lupus

Free access

Research article

First published 2020-5

Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week,open-label extension study

Stewart J Tepper, Messoud Ashina, Uwe Reuter [...]

Cephalalgia

Open access

Research article

First published 2024

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

James F. Howard, Saskia Bresch, Constantine Farmakidis [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2021

Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension

Sean J Pittock, Kazuo Fujihara, Jacqueline Palace [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024-6

Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS

Tanuja Chitnis, Brenda Banwell, Ludwig Kappos [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2019-2

Dienogest for Treatment of Endometriosis in Women: A 28-Week,Open-Label,Extension Study

Qi Yu, Shulan Zhang, Huajun Li [...]

Journal of Women's Health

Retricted access

Other

First published 2008-05

The MERCURY I open-label extension study — subgroup analysis in patients with diabetes

Herbert Schuster, Mike K Palmer, Marc Ditmarsch

The British Journal of Diabetes & Vascular Disease

Open access

Research article

First published 2021-10

Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study

Peter Rieckmann, Robert Zivadinov, Alexey Boyko [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Brief report

First published

A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension

Ruth Remington, Jevin J. Lortie, Heather Hoffmann [...]

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2019-01-08

Open-Label,Multicenter,Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer’s Disease

Lutz Frölich, Alireza Atri, Clive Ballard [...]

Journal of Alzheimer’s Disease

Search results